Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ONTO INNOVATION INC.
Report date May 10, 2022 · Filed May 10, 2022
Section 16 reporting ended · disclosed 2022-05-10. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2018 Filed Feb 26, 2018 21:50 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | Exercise / conversionCommon Stock | 3,333 | $15.74 | $52,461.42 |
DisclosureSEC source: 0001209191-18-013405 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 00:51 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066881 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,161 Read SEC document |
| December 08, 2017 Filed Dec 11, 2017 21:04 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064984 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,361 Read SEC document |
| December 01, 2017 Filed Dec 4, 2017 21:22 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-063545 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,961 Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 20:03 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | SaleCommon Stock | 10,000 | $29.47 | $294,700.00 |
DisclosureSEC source: 0001209191-17-038850 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736,561 Read SEC document |
| May 23, 2017 Filed May 25, 2017 21:09 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | GrantCommon Stock | 3,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035491 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746,561 F1 · shares: Shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of NANO common stock. The restricted stock units vest the sooner of May 23, 2018 or the next annual shareholder's meeting. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:56 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | SaleCommon Stock | 10,000 | $28.83 | $288,300.00 |
DisclosureSEC source: 0001209191-17-030995 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 743,108 F1 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $28.75 to $28.98. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 01:09 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155515 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 753,108 Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:58 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,038 | $0.00 Strike: $11.17 | $0.00 |
DisclosureSEC source: 0001209191-16-152526 · doc4.xml · derivative · entry 7 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,038 shares Expires 2017-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:58 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,040 | $0.00 Strike: $10.83 | $0.00 |
DisclosureSEC source: 0001209191-16-152526 · doc4.xml · derivative · entry 6 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,040 shares Expires 2017-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:58 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | SaleCommon Stock | 7,078 | $24.58 | $173,977.24 |
DisclosureSEC source: 0001209191-16-152526 · doc4.xml · nonDerivative · entry 4 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754,108 F2 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.55 to $24.64. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:58 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | SaleCommon Stock | 30,000 | $24.40 | $732,000.00 |
DisclosureSEC source: 0001209191-16-152526 · doc4.xml · nonDerivative · entry 3 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,186 F1 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.17 to $24.74. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:58 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | Exercise / conversionCommon Stock | 2,038 | $11.17 | $22,764.46 |
DisclosureSEC source: 0001209191-16-152526 · doc4.xml · nonDerivative · entry 2 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 791,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 22:58 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | Exercise / conversionCommon Stock | 5,040 | $10.83 | $54,583.20 |
DisclosureSEC source: 0001209191-16-152526 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 789,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 20:55 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | SaleCommon Stock | 10,000 | $22.08 | $220,800.00 |
DisclosureSEC source: 0001209191-16-144401 · doc4.xml · nonDerivative · entry 2 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784,108 F1 · kind: Transaction pursuant to a 10b5-1 Plan adopted December 11, 2014. F2 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $21.90 to $22.335. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 07, 2016 Filed Oct 4, 2016 20:55 UTC | ONTO INNOVATION INC. NANO · Entity 3340 | OtherCommon Stock | 779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144401 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 794,108 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.